
Saturday, August 20, 2022 5:04:22 PM

Liked By
Spread the love. Be the first to like this post!
Recent BWV News
- Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates • GlobeNewswire Inc. • 02/01/2023 02:15:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 01/31/2023 09:04:22 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/17/2023 01:36:38 PM
- Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors • GlobeNewswire Inc. • 01/17/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 01:51:07 PM
- Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco • GlobeNewswire Inc. • 01/09/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/06/2023 10:03:27 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 01/04/2023 12:14:06 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 01:41:31 PM
- Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives “Buy” Rating From Both • GlobeNewswire Inc. • 12/12/2022 01:30:00 PM
- Blue Water Vaccines, Inc. (BWV) Gets a Buy from H.C. Wainwright • TipRanks • 12/09/2022 11:25:11 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/06/2022 06:13:24 PM
- Blue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine Candidate • GlobeNewswire Inc. • 12/06/2022 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/01/2022 01:37:06 PM
- Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress • GlobeNewswire Inc. • 12/01/2022 01:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/21/2022 04:34:57 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/21/2022 02:32:53 PM
- Blue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San Antonio • GlobeNewswire Inc. • 11/21/2022 01:00:00 PM
- Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 11/14/2022 10:48:23 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 10:36:17 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:55:28 PM
- Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program • GlobeNewswire Inc. • 11/10/2022 01:47:52 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/09/2022 09:06:27 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/08/2022 02:30:22 PM
- Blue Water Vaccines Announces Appointment of Vuk Jeremić, Previous Chair of the Council of Europe’s Committee of Ministers and Previous President of the United Nations General Assembly, to Its Board of Directors • GlobeNewswire Inc. • 11/08/2022 01:30:00 PM
TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM
Hempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products • HPCO • Feb 2, 2023 9:30 AM
Kona Gold Beverage, Inc Announces Record Revenue Month in January Eclipsing Half a Million Dollars for the First Time • KGKG • Feb 2, 2023 9:00 AM
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm • BLFE • Feb 2, 2023 8:32 AM